Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07775287 |
| Title | Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2) |
| Acronym | LiGeR-CRC2 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Genmab |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Valkyrie Clinical Trials - Los Angeles | RECRUITING | Los Angeles | California | 90067 | United States | Details |
| Low Country Cancer Care Associates_Savannah_2 | RECRUITING | Savannah | Georgia | 31404 | United States | Details |
| Vista Oncology - West Olympia_Olympia_2 | RECRUITING | Olympia | Washington | 98502 | United States | Details |
| PanOncology | RECRUITING | Manati | 00674 | Puerto Rico | Details |